AU2002258606A1 - Aerosol administration of interleukin-2 liposomes - Google Patents

Aerosol administration of interleukin-2 liposomes

Info

Publication number
AU2002258606A1
AU2002258606A1 AU2002258606A AU2002258606A AU2002258606A1 AU 2002258606 A1 AU2002258606 A1 AU 2002258606A1 AU 2002258606 A AU2002258606 A AU 2002258606A AU 2002258606 A AU2002258606 A AU 2002258606A AU 2002258606 A1 AU2002258606 A1 AU 2002258606A1
Authority
AU
Australia
Prior art keywords
interleukin
liposomes
aerosol administration
aerosol
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002258606A
Inventor
Peter M. Anderson
Nizar N. ZEIN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mayo Foundation for Medical Education and Research
Original Assignee
Mayo Foundation for Medical Education and Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayo Foundation for Medical Education and Research filed Critical Mayo Foundation for Medical Education and Research
Publication of AU2002258606A1 publication Critical patent/AU2002258606A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Otolaryngology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002258606A 2001-03-30 2002-03-26 Aerosol administration of interleukin-2 liposomes Abandoned AU2002258606A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28020901P 2001-03-30 2001-03-30
US60/280,209 2001-03-30
PCT/US2002/009129 WO2002078624A2 (en) 2001-03-30 2002-03-26 Aerosol administration of interleukin-2 liposomes

Publications (1)

Publication Number Publication Date
AU2002258606A1 true AU2002258606A1 (en) 2002-10-15

Family

ID=23072127

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002258606A Abandoned AU2002258606A1 (en) 2001-03-30 2002-03-26 Aerosol administration of interleukin-2 liposomes

Country Status (2)

Country Link
AU (1) AU2002258606A1 (en)
WO (1) WO2002078624A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9669071B2 (en) * 2011-03-11 2017-06-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for stimulating T lymphocytes with IL-2
CN103732241A (en) * 2011-03-11 2014-04-16 公共事业救济局-巴黎医院 Use of low dose Il-2 for treating autoimmune - related or inflammatory disorders
MX2021010017A (en) 2019-02-20 2021-11-17 Ksl Biomedical Inc A method for predicting and monitoring the efficacy of low-dose il-2 and hydroxychloroquine therapy in autoimmune diseases and its long-term use in autoimmune-related conditions.

Also Published As

Publication number Publication date
WO2002078624A2 (en) 2002-10-10
WO2002078624A3 (en) 2004-01-08

Similar Documents

Publication Publication Date Title
WO2002089880A8 (en) Inhalers
AU2002234476A1 (en) Medical aerosol formulations
AU2002363005A1 (en) Derivatives of uk-2a
AU2002365120A1 (en) Medicaments
AU2002313236A1 (en) Medicinal compositions
AU2002364893A1 (en) Delivery of medicaments to the nail
AU6887401A (en) Delivery of remotely-ordered products
AU2002336340A1 (en) Non-integer division of frequency
AU2002339370A1 (en) Nasal Spray
AU2002240942A1 (en) Improved delivery of benefit agents
AU2002363546A1 (en) Provision of video-on-demand
AU2002258606A1 (en) Aerosol administration of interleukin-2 liposomes
AU2002357159A1 (en) MANUFACTURE OF TRIALKYLALUMINUM COMPOUNDS AND Alpha-ALCOHOLS
AU2002215923A1 (en) Use of medicaments
AU2002238748A1 (en) Pharmaceutical aerosol formulation
AU2002350154A1 (en) Preparation of polyethylene
AU2002359898A1 (en) Preparation of alpha-diimines
AU2002361450A1 (en) Novel pharmaceutical
AU2001276556A1 (en) Novel pharmaceutical use of quinnoline derivatives
AU2002346223A1 (en) Medicinal compositions
AU2002216038A1 (en) Preparation of monofluoroalkenes
AU2002300773A1 (en) Preparation of Dialkylpyridylboranes
AU2002235413A1 (en) Medicinal aerosols
AU2002339621A1 (en) Metallothioneine-containing liposomes
AU2002307921A1 (en) Liposomes

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase